Clinical Trial Update: Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children [Phase 1]

View source ↗

Summary

Phase 1 trial update shows results for Delgocitinib Cream in adults, adolescents, and children with moderate to severe atopic dermatitis over 8 weeks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Delgocitinib Cream (delgocitinib)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED